Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CDC7 | O00311 | 1/20 | 0.40 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 5/20 | 0.38 |
| ▸ | GABRB2 | P47870 | 5/20 | 0.38 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.38 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.38 |
| ▸ | AKT1 | P31749 | 1/20 | 0.38 |
| ▸ | AKT2 | P31751 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29892510 | 1.00 | MAPT (0.48) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL1868574 | 0.91 | MGAM (0.42) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL1869270 | 0.86 | MGAM (0.38) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL476664 | 0.86 | AKT1 (0.42) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL29370507 | 0.86 | AKT1 (0.42) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL1061886 | 0.82 | MAPT (0.43) | MAPTNPC1POLBTSHRRAB9A | |
| SCHEMBL476565 | 0.81 | HSD11B1 (0.42) | NPC1TSHRRAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL29389827 | 0.81 | HSD11B1 (0.42) | NPC1TSHRRAB9ASMN1; SMN2HSD17B10 | |
| SCHEMBL1062076 | 0.81 | AKT1 (0.39) | MAPTPOLBSMN1; SMN2KDM4ESLC2A1 | |
| SCHEMBL29893456 | 0.81 | AKT1 (0.39) | MAPTPOLBSMN1; SMN2KDM4ESLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240206322-A1 | OPTICAL SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING SAME, SOLID-STATE IMAGING DEVICE, AND ELECTRONIC DEVICE | KANEKA CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| EP-1999514-B1 | PHOTOSENSITIVE RESIST COMPOSITION FOR COLOR FILTERS FOR USE IN ELECTRONIC PAPER DISPLAY DEVICES | CIBA HOLDING INC (CH) | 2018-10-03 | — | — | EP | disclosed |
| US-9464172-B2 | Alkali-developable curable composition, insulating thin film using the same, and thin film transistor | KANEKA CORPORATION (JP) | 2016-10-11 | — | — | US | disclosed |
| US-8927182-B2 | Photosensitive resist composition for color filters for use in electronic paper display devices | BASF SE (DE) | 2015-01-06 | — | — | US | disclosed |
| US-8809414-B2 | Photocurable composition and cured product | KANEKA CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| EP-2236543-B1 | POLYSILOXANE COMPOUND, ALKALI-DEVELOPABLE CURABLE COMPOSITION, INSULATING THIN FILM USING THE SAME, AND THIN FILM TRANSISTOR | KANEKA CORP (JP) | 2014-02-26 | — | — | EP | disclosed |
| US-20110237702-A1 | PHOTOCURABLE COMPOSITION AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2011-09-29 | — | — | US | disclosed |
| EP-2343326-A1 | PHOTOCURABLE COMPOSITION AND CURED PRODUCT | Kaneka Corporation (JP) | 2011-07-13 | — | — | EP | disclosed |
| US-7935776-B2 | having a carboxy group in its main chain and a acryloyl group in its side chain; Color filters | AGI CORPORATION (TW) | 2011-05-03 | — | — | US | disclosed |
| US-20110001190-A1 | ALKALI-DEVELOPABLE CURABLE COMPOSITION, INSULATING THIN FILM USING THE SAME, AND THIN FILM TRANSISTOR | KANEKA CORPORATION (JP) | 2011-01-06 | — | — | US | disclosed |
| US-6120973-A | PHOTOSENSITIVE COMPOSITION AND COLORS WITH POLYMERS | JSR CORPORATION (JP) | 2000-09-19 | — | — | US | disclosed |
| EP-1033626-A1 | Radiation sensitive composition | JSR Corporation (JP) | 2000-09-06 | — | — | EP | disclosed |
| EP-1033625-A1 | Radiation sensitive composition | JSR Corporation (JP) | 2000-09-06 | — | — | EP | disclosed |
| US-6087050-A | Radiation sensitive composition and color filter | JSR CORPORATION (JP) | 2000-07-11 | — | — | US | disclosed |
| US-6013415-A | Radiation sensitive composition | JSR CORPORATION (JP) | 2000-01-11 | — | — | US | disclosed |
| EP-0902327-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1999-03-17 | — | — | EP | disclosed |
| EP-0893737-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1999-01-27 | — | — | EP | disclosed |
| EP-0881541-A1 | Radiation sensitive composition and color filter | JSR Corporation (JP) | 1998-12-02 | — | — | EP | disclosed |
| EP-0875788-A1 | Radiation sensitive composition for color filters | JSR Corporation (JP) | 1998-11-04 | — | — | EP | disclosed |
| EP-0866367-A2 | Radiation sensitive composition | JSR Corporation (JP) | 1998-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110001190-A1 | ALKALI-DEVELOPABLE CURABLE COMPOSITION, INSULATING THIN FILM USING THE SAME, AND THIN FILM TRANSISTOR | TET1, KDM4A, ASIC1 | MAPT 252/4885NPC1 3909/4885POLB 2943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.